University of Maryland School of Medicine logo
Emergency Medicine
All Departments
UMSOM Assistant
UMEM Educational Pearls
  • Home
  • Departments
  • Emergency Medicine
  • CME
  • UMEM Educational Pearls
  • CME
  • Courses and Conferences
  • Free Open Access Medical Education
  • UMEM Educational Pearls

Search

Title: Naltrexone vs. Methylnaltrexone

Category: Pharmacology & Therapeutics

Keywords: naltrexone, methylnaltrexone, constipation, opioid dependence (PubMed Search)

Posted: 6/2/2012 by Bryan Hayes, PharmD (Updated: 6/15/2012)

Naltrexone and methylnaltrexone are both mu-receptor antagonists that look similar and have similar names. But, they have very different uses.

  • Naltrexone (ReVia, Vivitrol)
    • Used to treat opioid/alcohol dependence or to prevent relapse following opioid detoxifcation
    • Dose: 25 to 100 mg PO daily or 380 IM every 4 weeks
    • Crosses blood-brain-barrier and can precipitate withdrawal
  • Methylnaltrexone (Relistor)
    • Used to treat opioid-induced constipation
    • Dose (weight-based): 8 to 12 mg (or 0.15 mg/kg) subcutaneously once daily
    • Peripherally acting, does not cross blood brain barrier

References

Follow me on Twitter (@pharmERtoxguy).


University of Maryland School of Medicine logo
  • Departments
  • Programs
  • Research Centers
  • Institutes
  • Graduate Education
  • CIBR Cores
  • Offices of the Dean
    • University of Maryland, Baltimore
    • University of Maryland Medical Center
    • Medical Alumni Association of the University of Maryland
    • Health Sciences and Human Services Library
University of Maryland School of Medicine
655 W. Baltimore Street
Baltimore, MD 21201
Contact Us

© University of Maryland School of Medicine

    • Webmaster
    • Web Accessibility
    • Site Index
    • UMB Hotline
    • Employment
    • Map